Insigma Technology (SHA:600797) said its joint-stock company completed listing on the Hong Kong Stock Exchange, according to a Shanghai Stock Exchange disclosure on Friday.
Hangzhou Jiuyuan Gene Engineering (HKG:2566) was listed on Nov. 28, offering 45.4 million shares for HK$12.42 apiece.
After the completion of the listing, the Chinese information technology services provider, through subsidiary Netnew Ventures, holds 24.5 million shares or 9.99% of Jiuyuan Gene Engineering. Netnew Ventures' lock-up period for Jiuyuan Gene shares is 12 months after the listing.
Insigma Technology's shares rose more than 2%, while Jiuyuan Gene Engineering's shares rose more than 4% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。